Q J Med 2001; 94: 435-444
© 2001 Association of Physicians
Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis
1 From the Division of Obstetrical Medicine, Department of Medicine, Women's College Campus, Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, and, 2 Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
Received 8 April 2001 and in revised form 20 May 2001
Offspring of women with pregestational diabetes mellitus are at increased risk for congenital malformations, largely attributable to poor periconceptional glycaemic control. We assessed the effect of preconception care in reducing congenital malformations, in a meta-analysis of published studies of preconception care in women with diabetes mellitus. Articles were retrieved from Medline (1970 to June 2000) and Embase (1980 to June 2000), and data abstracted by two independent reviewers. The rates and relative risks (RR) for major and minor congenital malformations were pooled from all eligible studies using a random effects model, as were early first-trimester glycosylated haemoglobin values. In 14 cohort studies, major congenital malformations were assessed among 1192 offspring of mothers who had received preconception care, and 1459 offspring of women who had not. The pooled rate of major anomalies was lower among preconception care recipients (2.1%) than non-recipients (6.5%) (RR 0.36, 95%CI 0.22–0.59). In nine studies, the risk for major and minor anomalies was also lower among women who received preconception care (RR 0.32, 95%CI 0.17–0.59), as were the early first-trimester mean glycosylated haemoglobin values (pooled mean difference: 2.3%, 95%CI 2.1–2.4). Women who received preconception care were, on average, 1.8 years older than non-recipients, and fewer smoked (19.6% vs. 30.2%). Only one study described the routine use of periconception folic acid. Out-patient preconception care probably reduces the risk of major congenital anomalies among the offspring of women with pregestational diabetes mellitus. Because many women with diabetes neither plan their pregnancy nor achieve adequate glycaemic control before conception, strategies are needed to improve access to these programs, and to maximize those interventions associated with improved pregnancy outcome, such as smoking cessation and folic acid use.
Address correspondence to Dr J.G. Ray. e-mail: rayjg{at}mcmaster.ca
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E Keely Type 2 diabetes in pregnancy: importance of optimized care before, during and after pregnancy Obstet Med, December 1, 2008; 1(2): 72 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Kumar, S.-K. Yong, S. T. Dheen, B.-H. Bay, and S. S.-W. Tay Cardiac Malformations Are Associated with Altered Expression of Vascular Endothelial Growth Factor and Endothelial Nitric Oxide Synthase Genes in Embryos of Diabetic Mice Experimental Biology and Medicine, November 1, 2008; 233(11): 1421 - 1432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Coustan A 40-Year-Old Woman With Diabetes Contemplating Pregnancy After Gastric Bypass Surgery JAMA, June 4, 2008; 299(21): 2550 - 2557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Kitzmiller, J. M. Block, F. M. Brown, P. M. Catalano, D. L. Conway, D. R. Coustan, E. P. Gunderson, W. H. Herman, L. D. Hoffman, M. Inturrisi, et al. Managing Preexisting Diabetes for Pregnancy: Summary of evidence and consensus recommendations for care Diabetes Care, May 1, 2008; 31(5): 1060 - 1079. [Full Text] [PDF]
|
|
|
|
 |
|
 R.B. Fraser, S.L. Waite, K.A. Wood, and K.L. Martin Impact of hyperglycemia on early embryo development and embryopathy: in vitro experiments using a mouse model Hum. Reprod., December 1, 2007; 22(12): 3059 - 3068. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Murphy, G. Rayman, K. Duffield, K. S. Lewis, S. Kelly, B. Johal, D. Fowler, and R. C. Temple Changes in the Glycemic Profiles of Women With Type 1 and Type 2 Diabetes During Pregnancy Diabetes Care, November 1, 2007; 30(11): 2785 - 2791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Guerin, R. Nisenbaum, and J. G. Ray Use of Maternal GHb Concentration to Estimate the Risk of Congenital Anomalies in the Offspring of Women with Prepregnancy Diabetes Diabetes Care, July 1, 2007; 30(7): 1920 - 1925. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Jenkins, A. Correa, J. A. Feinstein, L. Botto, A. E. Britt, S. R. Daniels, M. Elixson, C. A. Warnes, and C. L. Webb Noninherited Risk Factors and Congenital Cardiovascular Defects: Current Knowledge: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young: Endorsed by the American Academy of Pediatrics Circulation, June 12, 2007; 115(23): 2995 - 3014. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. R Murphy, R. C Temple, and J. M Roland Improving outcomes of pregnancy for women with type 1 and type 2 diabetes The British Journal of Diabetes & Vascular Disease, January 1, 2007; 7(1): 38 - 42. [Abstract] [PDF]
|
|
|
|
|
|
R. C. Temple, V. J. Aldridge, and H. R. Murphy Prepregnancy Care and Pregnancy Outcomes in Women With Type 1 Diabetes Diabetes Care, August 1, 2006; 29(8): 1744 - 1749. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Harris and R. D. White Diabetes Management and Exercise in Pregnant Patients With Diabetes Clin. Diabetes, October 1, 2005; 23(4): 165 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Saydah, A. Chandra, and M. S. Eberhardt Pregnancy Experience Among Women With and Without Gestational Diabetes in the U.S., 1995 National Survey of Family Growth Diabetes Care, May 1, 2005; 28(5): 1035 - 1040. [Abstract] [Full Text] [PDF]
|
|